NCT01167127View on ClinicalTrials.gov

Oxycodone/Naloxone (OXN) Combination in Moderate to Severe Non-malignant Pain

PHASE3CompletedINTERVENTIONAL
Enrollment

113

Participants

Timeline

Start Date

June 30, 2009

Primary Completion Date

April 30, 2011

Study Completion Date

April 30, 2011

Conditions
Pain
Interventions
DRUG

Oxycodone hydrochloride and naloxone hydrochloride combination, prolonged release

OXN Tablet, oral, BID, flexible dose design

Trial Locations (1)

Unknown

Leeuwarden

Sponsors
All Listed Sponsors
lead

Mundipharma Pharmaceuticals B.V.

INDUSTRY